Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9099 | 1121 | 30.9 | 77% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1420 | 7495 | ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY//CYTOMETRY//IMAGE CYTOMETRY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PCNA | Author keyword | 18 | 11% | 15% | 166 |
2 | PROLIFERATING CELL NUCLEAR ANTIGEN | Author keyword | 14 | 12% | 10% | 117 |
3 | PKI 67 | Author keyword | 11 | 69% | 1% | 9 |
4 | PC10 | Author keyword | 9 | 59% | 1% | 10 |
5 | PROLIFERATING CELL NUCLEAR ANTIGEN PCNA | Author keyword | 5 | 15% | 3% | 30 |
6 | PCNA PROLIFERATING CELL NUCLEAR ANTIGEN | Author keyword | 3 | 50% | 0% | 5 |
7 | LG TUMORBIOL | Address | 3 | 100% | 0% | 3 |
8 | GROWTH FRACTION | Author keyword | 3 | 19% | 1% | 15 |
9 | PCNA CYCLIN | Author keyword | 3 | 50% | 0% | 4 |
10 | PROLIFERATION ASSOCIATED ANTIGEN | Author keyword | 3 | 60% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PCNA | 18 | 11% | 15% | 166 | Search PCNA | Search PCNA |
2 | PROLIFERATING CELL NUCLEAR ANTIGEN | 14 | 12% | 10% | 117 | Search PROLIFERATING+CELL+NUCLEAR+ANTIGEN | Search PROLIFERATING+CELL+NUCLEAR+ANTIGEN |
3 | PKI 67 | 11 | 69% | 1% | 9 | Search PKI+67 | Search PKI+67 |
4 | PC10 | 9 | 59% | 1% | 10 | Search PC10 | Search PC10 |
5 | PROLIFERATING CELL NUCLEAR ANTIGEN PCNA | 5 | 15% | 3% | 30 | Search PROLIFERATING+CELL+NUCLEAR+ANTIGEN+PCNA | Search PROLIFERATING+CELL+NUCLEAR+ANTIGEN+PCNA |
6 | PCNA PROLIFERATING CELL NUCLEAR ANTIGEN | 3 | 50% | 0% | 5 | Search PCNA+PROLIFERATING+CELL+NUCLEAR+ANTIGEN | Search PCNA+PROLIFERATING+CELL+NUCLEAR+ANTIGEN |
7 | GROWTH FRACTION | 3 | 19% | 1% | 15 | Search GROWTH+FRACTION | Search GROWTH+FRACTION |
8 | PCNA CYCLIN | 3 | 50% | 0% | 4 | Search PCNA+CYCLIN | Search PCNA+CYCLIN |
9 | PROLIFERATION ASSOCIATED ANTIGEN | 3 | 60% | 0% | 3 | Search PROLIFERATION+ASSOCIATED+ANTIGEN | Search PROLIFERATION+ASSOCIATED+ANTIGEN |
10 | KI 67 ANTIBODY | 2 | 32% | 1% | 6 | Search KI+67+ANTIBODY | Search KI+67+ANTIBODY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PCNA CYCLIN | 53 | 59% | 5% | 60 |
2 | AUXILIARY PROTEIN | 47 | 26% | 14% | 158 |
3 | DNA POLYMERASE DELTA | 41 | 23% | 14% | 160 |
4 | CYCLIN PCNA | 38 | 39% | 7% | 76 |
5 | GROWTH FRACTION | 28 | 30% | 7% | 79 |
6 | MONOCLONAL ANTIBODY KI 67 | 27 | 17% | 13% | 146 |
7 | CYCLIN | 23 | 18% | 11% | 118 |
8 | PROLIFERATION RELATED ANTIGEN | 20 | 51% | 2% | 28 |
9 | PROTEIN CYCLIN | 16 | 65% | 1% | 15 |
10 | PCNA | 16 | 11% | 12% | 133 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The Ki-67 protein: From the known and the unknown | 2000 | 1707 | 83 | 35% |
Ki67 protein: the immaculate deception? | 2002 | 292 | 135 | 21% |
THE PROLIFERATION-ASSOCIATED KI-67 PROTEIN - DEFINITION IN MOLECULAR TERMS | 1994 | 75 | 31 | 71% |
THE ASSESSMENT OF CELLULAR PROLIFERATION BY IMMUNOHISTOCHEMISTRY - A REVIEW OF CURRENTLY AVAILABLE METHODS AND THEIR APPLICATIONS | 1992 | 246 | 65 | 62% |
Antibodies against the Ki-67 protein: Assessment of the growth fraction and tools for cell cycle analysis | 2001 | 18 | 73 | 66% |
The clinical significance of autoantibodies to the proliferating cell nuclear antigen (PCNA) | 2012 | 8 | 34 | 41% |
UPDATE ON PROLIFERATION-ASSOCIATED ANTIBODIES APPLICABLE TO FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE AND THEIR CLINICAL-APPLICATIONS | 1993 | 119 | 67 | 72% |
A personal account of the early stages of proteomics at Aarhus University | 2014 | 2 | 32 | 41% |
Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation | 2011 | 70 | 156 | 17% |
TOXICOLOGICAL AND PATHOLOGICAL APPLICATIONS OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA), A NOVEL ENDOGENOUS MARKER FOR CELL-PROLIFERATION | 1993 | 137 | 133 | 47% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LG TUMORBIOL | 3 | 100% | 0.3% | 3 |
2 | CHILDHOOD SURG | 1 | 100% | 0.2% | 2 |
3 | ABT IMMUNOL ZELLBIOL | 1 | 23% | 0.3% | 3 |
4 | ABT INTELLIGENTE SYST | 1 | 50% | 0.1% | 1 |
5 | ANTIBODIES DESIGN | 1 | 50% | 0.1% | 1 |
6 | CNR IMMUNOGENET EXPT ONCOL | 1 | 50% | 0.1% | 1 |
7 | IST TISIOL MALATTIE P S MARCATILI | 1 | 50% | 0.1% | 1 |
8 | KB SPLIT | 1 | 50% | 0.1% | 1 |
9 | NUCL ORG DURING PLANT DEV | 1 | 50% | 0.1% | 1 |
10 | PATHOL MIYAGINO KU | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000150477 | POTENTIAL DOUBLING TIME//BROMODEOXYURIDINE//IODODEOXYURIDINE |
2 | 0.0000139615 | P120//NONHISTONE CHROMOSOMAL PROTEINS//EXPTL PATHOL SECT |
3 | 0.0000133851 | NUCLEOLAR ORGANIZER REGIONS//AGNOR//AGNORS |
4 | 0.0000127533 | PROLIFERATING CELL NUCLEAR ANTIGEN CYCLIN//BRASILENSE//IMMUNE MEDIATED THROMBOCYTOPENIC PURPURA |
5 | 0.0000117604 | DNA MULTIPLOIDY//DNA PLOIDY//DNA PLOIDY HETEROGENEITY |
6 | 0.0000106631 | S PHASE FRACTION//ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY//DNA PLOIDY |
7 | 0.0000091168 | DREF//INSECT BIOMED//DNA REPLICATION RELATED GENE |
8 | 0.0000082326 | CLAMP LOADER//REPLICATION FACTOR C//DNA REPLICAT |
9 | 0.0000079539 | DNA POLYMERASE ALPHA//DNA SYNTHESOME//DNA POLYMERASE DELTA |
10 | 0.0000066656 | ADENOMATOUS HYPERPLASIA//MACROREGENERATIVE NODULES//LIVER CELL DYSPLASIA |